A vaccine that slows the progression of Alzheimer’s disease in mice has been developed by researchers at Sydney University.
The vaccine targets a protein known as tau. It prevents the ongoing formation of neurofibrillary tangles in the brain of a mouse with Alzheimer’s disease.
“Our study is the first to show that a vaccine targeting the tau protein can be effective once the disease has already set in,” said lead author on the study Associate Professor Lars Ittner. “The vaccine appears to have a preventative effect.”
“Although we have a long way to go before the vaccine might be available for human use, these early results are very promising.”
The research is published in the journal PLoS ONE.
Read more at University of Sydney